Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 22, 2017
Pharmacy Choice - News - Front Page Healthcare News - July 22, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/22/17 - "Kinase Inhibitors" in Patent Application Approval Process (USPTO 20170183343)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors CAPALDI, Carmelida; ARMANI, Elisabetta; JENNINGS, Andrew Steven Robert; HURLEY, Christopher, filed on December 22, 2016, was made available online on July 6, 2017, according to news reporting originating from Washington, D.C., by NewsRx c
7/22/17 - AMA Urges Senate to Reject Efforts to Repeal or Replace ACA
The American Medical Association issued the following news release:. The American Medical Association today outlined its opposition to current efforts in the U.S. Senate aimed at replacing or repealing the Affordable Care Act, citing the loss of affordable coverage for millions of patients. On behalf of the physician and medical student members of
7/22/17 - Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK [Arab Times (Kuwait)]
The pharma giants said Thursday afternoon that the FDA has accepted their application for erenumab, the furthest advanced CGRP therapy which is now navigating toward a May 17 PDUFA date. But payers will also be expected to consider Eli Lillys 2- day advantage, or a Phase III outcome for Amgen and Novartis that was quite similar to Alders for 70 mg
7/22/17 - Anti-Thrombin Activators Market: Upcoming Demands and Growth Analysis 2024
Transparency Market Research Report Added "Anti-thrombin Activators Market" to its database.Albany, NY 07/21/2017 Anti-thrombin activators are widely accepted due to their role in reducing thrombus formation. Anticoagulants, anti-platelet drugs, and thrombolytic drugs are some of the different types of anti-thrombin activators available, whic
7/22/17 - AP Top Health News at 8:15 a.m. EDT
Mixed signals from Trump White House on health care strategy No dye: Cancer patients' gray hair darkened on immune drugs Native Hawaiians not very healthy, first national study says House unveils plan to fix VA's budget gap as deadline looms Doctors' group tells Senate to fix, not repeal' Obamacare' Endurance athlete overcomes paralysis to race, co
7/22/17 - BrainStorm Wins $15.9M CIRM Grant for Phase III Trial of ALS Cell Therapy [Sport360]
BrainStorm Cell Therapeutics has won a $15.9 million grant from Californias regenerative medicine agency toward a Phase III trial of its amyotrophic lateral sclerosis cell therapy candidate NurOwn. NurOwn technology was developed in the laboratories of Dani Offen, Ph.D., and the late Eldad Melamed, M.D., at Tel Aviv University. BrainStorm said it i
7/22/17 - Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT for the Treatment of Pulmonary Arterial Hypertension
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Cardiome Pharma Corp. announced that partner SteadyMed Ltd submitted a New Drug Application to the U.S. Food and Drug Administration for TREVYENT . TREVYENT is a drug-device combination product that utilizes SteadyMed's PatchPump technology to deliver treprostinil, a.
7/22/17 - CHILDREN WILL BE AFFECTED IF OBAMACARE IS REPEALED
For over seven years, Republicans have campaigned on the idea of repealing the Affordable Care Act. Now in control of both the White House and Congress, Republicans are faced with the harsh reality of the consequences of trying to rip health care from millions of people. Seniors and hardworking families across New Jersey would either lose their cur
7/22/17 - CHMP Recommends EU Approval for Roche's TECENTRIQ (Atezolizumab) in a Specific Type of Metastatic Lung and Two Types of Metastatic Bladder Cancer
Roche, a biotech company, issued the following news release:. Roche today announced that the EU Committee for Medicinal Products for Human Use has adopted a positive opinion for TECENTRIQ (R) as a monotherapy for the treatment of adults with locally advanced or metastatic non-small cell lung cancer after they have been previously treated with chemo
7/22/17 - Collapse of GOP health care push reflects shift in the debate
Supporters of the 2010 law cannot rest easy as long as the current Congress remains in office and as long as Donald Trump occupies the White House. Congress can undermine the act through sharp Medicaid cuts in the budget process and other measures. "We'll let Obamacare fail, and then the Democrats are going to come to us," Trump said after it beca
7/22/17 - Congress needs to come home and stay
In their fervor to repeal and replace Obamacare, our Congress has run head first into a wall of political reality: once you extend benefits to people it is almost impossible to take them away. Despite all the bluff and bluster, Congress can t come up with the needed votes to replace Obamacare, nor do they have the numbers to repeal it. North Car
7/22/17 - Dems Unveil Health Care Plan
West Lebanon The two Democratic lawmakers representing the Upper Valley in the U.S. House said on Friday they are ready to talk with Republicans about ways to fix the Affordable Care Act, should the GOP give up efforts to repeal the health care law. Annie Kuster, D- N.H., and Peter Welch, D- Vt., who both supported the ACA when it was enacted, s
7/22/17 - Drug prices negotiated downward [China Daily: US Edition]
The prices of 36 expensive drugs- half of them for cancer treatment- are now covered by medical insurance, after the authorities negotiated substantial price reductions. The Ministry of Human Resources and Social Security negotiated with pharmaceutical manufacturers on 44 drugs and managed to cut prices of 36 of them to be acceptable for coverage b
7/22/17 - E.J. DIONNE, JR.: Here's why Obamacare won and President Trump lost
Supporters of the 2010 law cannot rest easy as long as the current Congress remains in office and as long as Donald Trump occupies the White House. Congress can undermine the act through sharp Medicaid cuts in the budget process and other measures. "We'll let Obamacare fail, and then the Democrats are going to come to us," Trump said after it beca
7/22/17 - EDITORIAL: Obamacare needs a nip-and-tuck job, not major surgery to survive [The Philadelphia Inquirer]
But instead of addressing its flaws, Republicans used the wave of public displeasure with Obamacare to solidify its hold on both houses of Congress and win the presidency. The Republicans should salve the wounds to their pride and collaborate with Democrats on legislation that would improve the ACA. Outside Washington, Americans can only hope Democ
7/22/17 - EDITORIAL: Saturday Readers share experiences with health insurance [The Florida Times-Union, Jacksonville]
July 22 There are few public policy issues that are so intensely personal as health insurance. If you're sick, it dominates your life. So with Congress debating the repeal and replacement of the Affordable Care Act, we asked members of the Email Interactive Group for their personal experiences on health care.
7/22/17 - Egalet Announces Pricing of Public Offering of Common Stock and Warrants
By a News Reporter-Staff News Editor at Marketing Weekly News Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, announced the pricing of its underwritten public offering of 16,666,667 shares of its common stock and...
7/22/17 - Ema's Chmp Issues Positive Opinion for Avelumab for Treatment of Metastatic Merkel Cell Carcinoma
Pfizer, a pharmaceutical company, issued the following news release:. Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of avelumab* as
7/22/17 - FDA approves drug to reduce risk of HER2-positive breast cancer returning [Arab Finance (Egypt)]
The US Food and Drug Administration has approved neratinib as the first extended adjuvant therapy for early-stage, HER2-positive breast cancer. Neratinib is a kinase inhibitor that works by blocking several enzymes that promote cell growth. Richard Pazdur, director of FDAs Oncology Center of Excellence and acting director of the Office of Hematolog
7/22/17 - FDA Clears First Neonatal Magnetic Resonance Imaging Device
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:. Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging device specifically for neonatal brain and head imaging in neonatal intensive care units. "Although we can use traditional MRI scanners to image
7/22/17 - FDA clears first neonatal magnetic resonance imaging device [Syrian Arab News Agency]
Today, the US Food and Drug Administration cleared the first magnetic resonance imaging device specifically for neonatal brain and head imaging in neonatal intensive care units. Although we can use traditional MRI scanners to image neonates, taking babies outside of the neonatal intensive care unit to MRI suites presents great challenges, said Vasu
7/22/17 - Global Medical Device Technologies Market 2017 IBM Corporation, Google Inc., Amazon Web Services, Microsoft Corporation, BigMl Inc., FICO, Yottamine Analytics, Ersatz Labs Inc, Predictron Labs Ltd, H2O.ai [Mehr News Agency (Iran)]
Market segment by Type, Medical Device Technologies can be split into. Market segment by Application, Medical Device Technologies can be split into. The report additionally concentrates the Medical Device Technologies bits of knowledge of the organizations and suggestions that will help the perusers to have progressive learning of the Medical Devic
7/22/17 - Global Outlook for Cold Plasma Market by Key Trends and Analysis 2026
Transparency Market Research Report Added "Cold Plasma Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016- 2026". Albany, NY 07/21/2017 Cold Plasma Market: Overview Cold plasma, popularly known as non-thermal plasma, is the new cutting edge concept that has wide applications in medical devices. The technology has
7/22/17 - GSK Receives FDA Approval for a New Self-Injectable Formulation of Benlysta (Belimumab) for Systemic Lupus Erythematosus
GlaxoSmithKline issued the following news release:. GSK announced today that the US Food and Drug Administration has approved a new subcutaneous formulation of Benlysta for the treatment of adult patients with active, autoantibody positive SLE who are receiving standard therapy. Systemic Lupus Erythematosus is the most common form of lupus, a ch
7/22/17 - Health care in a time of sabotage
Even now, it's hard to be sure, especially given Republican moderates' long track record of caving in to extremists at crucial moments. But it does look as if the frontal assault on the Affordable Care Act has failed. And let's be clear: The reason this assault failed wasn't that Donald Trump did a poor selling job or that Mitch McConnell mishandle
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415